Currently out of the existing stock ratings of Jack Meehan, 37 are a BUY (40.66%), 36 are a HOLD (39.56%), 18 are a SELL (19.78%).

Jack Meehan

Work Performance Price Targets & Ratings Chart

Analyst Jack Meehan, currently employed at BARCLAYS, carries an average stock price target met ratio of 93.29% that have a potential upside of 29.37% achieved within 271 days.

Jack Meehan’s has documented 181 price targets and ratings displayed on 21 stocks. The coverage is on Healthcare, Consumer Cyclical, Basic Materials sectors.

Most recent stock forecast was given on LH, Laboratory of America Holdings at 31-Jul-2026.

Wall Street Analyst Jack Meehan

Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 9/3/2019. The price target of $13.5 was fulfilled within 9 days with a profit of $2.3 (20.54%) receiving and performance score of 22.82.

Average potential price target upside

of $60.18 (7.62%) on MTD (METTLER-TOLEDO INTERNATIONAL).
of $54.06 (19.24%) on ILMN (ILLUMINA).
of $46.7 (17.5%) on BIO (BIO-RAD LABORATORIES).

HOLX Hologic MYGN Myriad Genetics PDD Pinduoduo A Agilent Technologies TMO Thermo Fisher Scientific DGX Quest Diagnostics ILMN Illumina QGEN Qiagen NV BIO Bio-Rad Laboratories INMD InMode Ltd IQV IQVIA Holdings MTD Mettler-Toledo International WAT Waters LH Laboratory of America Holdings BRKR Bruker GHDX Genomic Health ICLR ICON PLC PKI PerkinElmer AA Alcoa Corp AVTR Avantor QDEL Quidel

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

David Toung (ARGUS)